Jon P. Stonehouse

Jon P. Stonehouse

Former President and Chief Executive OfficeratBiocryst Pharmaceuticals· In proxies 2021–2025

Pay in FY2024+74% from the year before · Biocryst Pharmaceuticals stock +25.5% the same year

Jon P. Stonehouse was paid $8.3M in FY2024 (Dec), up 74%. Biocryst Pharmaceuticals stock rose 25.5% that year.

Pay$100 in the stock at the end of FY20 → $101
Pay is from the Summary Compensation Table of each Biocryst Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Biocryst PharmaceuticalsPublic company · 5 yr
    • Former President and Chief Executive Officer2021 – Present · 5 yrStock in role +15%
  2. Metsera, Inc.Public company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  3. Bellicum Pharmaceuticals, Inc.Public company · 10 yr
    • Director2014 – 2024 · 10 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?